Subclinical Tubular Injury in HIV-Infected Individuals on Antiretroviral Therapy: A Cross-sectional Analysis

被引:63
作者
Hall, Andrew M. [1 ,2 ]
Edwards, Simon G. [3 ]
Lapsley, Marta [4 ,5 ]
Connolly, John O. [2 ]
Chetty, Kreesan [3 ]
O'Farrell, Stephen [3 ]
Unwin, Robert J. [2 ]
Williams, Ian G. [3 ,6 ]
机构
[1] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England
[2] UCL, Ctr Nephrol, London WC1E 6BT, England
[3] Camden Primary Care Trust, Mortimer Market Ctr, London, England
[4] SW Thames Inst Renal Res, Epsom, Surrey, England
[5] St Helier Univ Hosp, Natl Hlth Serv Trust, Carshalton, Surrey, England
[6] UCL, Ctr Sexual Hlth & HIV Res, London WC1E 6BT, England
关键词
HIV; renal tubule; antiretroviral therapy; tenofovir; proteinuria; RETINOL-BINDING-PROTEIN; BETA-D-GLUCOSAMINIDASE; FANCONI-SYNDROME; RENAL-FAILURE; TENOFOVIR; URINE; BETA-2-MICROGLOBULIN; NEPHROTOXICITY; MICROGLOBULIN; DYSFUNCTION;
D O I
10.1053/j.ajkd.2009.07.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Randomized control studies have not shown an association between treatment with tenofovir (TDF) and clinically significant kidney toxicity. However, multiple cases of renal tubular toxicity have been described in patients with HIV treated with TDF It is unclear whether spot urine protein- or albumin-creatinine ratio is a sufficiently sensitive screening test to detect subclinical renal tubular toxicity in patients with HIV. Study Design: Cross-sectional. Setting & Participants: 99 patients with HIV with serum creatinine levels < 1.70 mg/dL and dipstick-negative proteinuria; 19 were antiretroviral treatment (ART) naive, 47 were on a TDF regimen, and 33 were on ART, but with no history of TDF exposure. Predictor or Factor: Exposure to TDF. Outcomes: Spot urine concentrations of retinol-binding protein (RBP; a low-molecular-weight protein normally reabsorbed by the proximal tubule), N-acetyl-beta-D-glucosaminidase (NAG; a proximal tubule lysosomal enzyme), albumin (A; a marker of glomerular disease), and protein (P; a standard clinical screening test for kidney pathological states) expressed as a ratio to creatinine (C; U(RBP/C), U(NAG/C) U(A/C), and U(P/C), respectively). Results: There were no significant differences in median U(A/C) (ART-naive, 7.3 mg/g [range, 0-245.8 mg/g]; TDF, 9.0 mg/g [range, 0.1-184.1 mg/g]; and non-TDF, 10.5 mg/g [range, 2.6-261.6 mg/g]; P = 0.8). U(RBP/C) excretion was significantly higher in the TDF group (median, 214.2 mu g/g [range, 26.8-17,454.5 mu g/g]) than in the ART-naive group (92.5 mu g/g [range, 21.3-3,969.0 mu g/g]; P = 0.03); there was also a trend toward higher values than in the non-TDF group (111.6 mu g/g [range, 31.0-6,136.3 mu g/g]; P = 0.08). U(NAG/C) excretion was significantly higher in both the TDF (median, 394.7 mu mol/h/g [range, 140.5-10,851.3 mu mol/h/g]; P = 0.01) and non-TDF (406.8 mu mol/h/g [range, 12.4-8,485.8 mu mol/h/g]; P = 0.03) groups compared with the ART-naive group (218.6 mu mol/h/g [range, 56.5-2,876.1 mu mol/h/g]). U(P/C) was significantly higher in the TDF (median, 123.9 mg/g [range, 53.1-566.4 mg/g]) than the non-TDF group (97.3 mg/g [range, 0-451.3 mg/g]; P = 0.03). The proportion of patients with evidence of tubular dysfunction (increased U(RBP/C) and/or U(NAG/C)) was considerably higher than the proportion with an increase in U(A/C) or U(P/C) in all groups: for ART-naive, 52.6% vs 31.6% vs 25.0%; for TDF, 80.9% vs 29.8% vs 52.2%; and for non-TDF, 81.8% vs 39.4% vs 30.0%. The level of agreement among the different urinary test results was low. Limitations: Causality cannot be established from single measurements of urinary markers in a cross-sectional study. Conclusions: Patients with HIV had high rates of subclinical proteinuria, but neither U(P/C) nor U(A/C) is sufficiently sensitive alone to detect many of these cases. Patients using TDF have increased U(RBP/C) and U(P/C); the significance of this will need to be determined from longer-term outcome studies. Am J Kidney Dis 54:1034-1042. (C) 2009 by the National Kidney Foundation, Inc.
引用
收藏
页码:1034 / 1042
页数:9
相关论文
共 27 条
[1]   COMPARISON OF RETINOL-BINDING PROTEIN AND BETA-MICROGLOBULIN DETERMINATION IN URINE FOR THE EARLY DETECTION OF TUBULAR PROTEINURIA [J].
BERNARD, AM ;
MOREAU, D ;
LAUWERYS, R .
CLINICA CHIMICA ACTA, 1982, 126 (01) :1-7
[2]  
BERNARD AM, 1981, CLIN CHEM, V27, P1781
[3]  
Brodehl J, 1992, PEDIAT KIDNEY DIS, P1841
[4]  
DAVEY PG, 1982, CLIN CHEM, V28, P1330
[5]   Urinary β2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil furnarate [J].
Gatanaga, Hiroyuki ;
Tachikawa, Natsuo ;
Kikuchi, Yoshimi ;
Teruya, Katsuji ;
Genka, Ikumi ;
Honda, Miwako ;
Tanuma, Junko ;
Yazaki, Hirohisa ;
Ueda, Akihiro ;
Kimura, Satoshi ;
Oka, Shinichi .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (08) :744-748
[6]   USE OF SINGLE VOIDED URINE SAMPLES TO ESTIMATE QUANTITATIVE PROTEINURIA [J].
GINSBERG, JM ;
CHANG, BS ;
MATARESE, RA ;
GARELLA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (25) :1543-1546
[7]   Long-term renal safety of tenofovir disoproxil fumurate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study [J].
Izzedine, H ;
Hulot, JS ;
Vittecoq, D ;
Gallant, JE ;
Staszewski, S ;
Launay-Vacher, V ;
Cheng, A ;
Deray, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (04) :743-746
[8]   Drug-induced Fanconi's syndrome [J].
Izzedine, H ;
Launay-Vacher, V ;
Isnard-Bagnis, C ;
Deray, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (02) :292-309
[9]   Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy [J].
Izzedine, Hassane ;
Hulot, Jean-Sebastien ;
Villard, Eric ;
Goyenvalle, Catherine ;
Dominguez, Stephanie ;
Ghosn, Jade ;
Valantin, Marc Antoine ;
Lechat, Philippe ;
Deray, Gilbert .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (11) :1481-1491
[10]   Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently - A cohort and case-control study [J].
Jones, R ;
Stebbing, J ;
Nelson, M ;
Moyle, G ;
Bower, M ;
Mandalia, S ;
Gazzard, B .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (04) :1489-1495